STEBRONIX Trademark 97372859 - Trademark Alertz

Trademark: 97372859

Word

STEBRONIX

Status

Registered

Status Code

700

Status Date

Tuesday, April 18, 2023

Serial Number

97372859

Registration Number

7030970

Registration Date

Tuesday, April 18, 2023

Mark Type

4000

Filing Date

Wednesday, April 20, 2022

Published for Opposition

Tuesday, January 31, 2023

Trademark Owner History

Glaxo Group Limited - Original Registrant

Classifications

5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events

Apr 18, 2023

Notice Of Registration Confirmation Emailed

Apr 18, 2023

Registered-Principal Register

Jan 31, 2023

Official Gazette Publication Confirmation E-Mailed

Jan 31, 2023

Published For Opposition

Jan 11, 2023

Notification Of Notice Of Publication E-Mailed

Dec 28, 2022

Approved For Pub - Principal Register

Dec 27, 2022

Assigned To Examiner

Nov 9, 2022

Teas Change Of Correspondence Received

Nov 9, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Nov 9, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Apr 26, 2022

New Application Office Supplied Data Entered

Apr 23, 2022

New Application Entered

HCAREDEE

Trademark Alertz updated from USPTO on 2030-01-24